Modern risk stratification of acute myeloid leukemia in 2023: integrating established and emerging prognostic factors

E Boscaro, I Urbino, FM Catania, G Arrigo, C Secreto… - Cancers, 2023 - mdpi.com
Simple Summary Several factors, both patient-and disease-related, are essential to
accurately estimate acute myeloid leukemia (AML) prognosis. The rapidly evolving field …

The multifaceted roles of cohesin in cancer

M Di Nardo, MM Pallotta, A Musio - Journal of Experimental & Clinical …, 2022 - Springer
The cohesin complex controls faithful chromosome segregation by pairing sister chromatids
after DNA replication until mitosis. In addition, it is crucial for hierarchal three-dimensional …

Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implication

N Jahn, T Terzer, E Sträng, A Dolnik… - Blood …, 2020 - ashpublications.org
Core-binding factor (CBF) acute myeloid leukemia (AML) encompasses AML with inv
(16)(p13. 1q22) and AML with t (8; 21)(q22; q22. 1). Despite sharing a common pathogenic …

Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification

T Liu, J Rao, W Hu, B Cui, J Cai, Y Liu, H Sun… - Nature …, 2022 - nature.com
Studies have revealed key genomic aberrations in pediatric acute myeloid leukemia (AML)
based on Western populations. It is unknown to what extent the current genomic findings …

Proteogenomic analysis reveals cytoplasmic sequestration of RUNX1 by the acute myeloid leukemia–initiating CBFB:: MYH11 oncofusion protein

RB Day, JA Hickman, Z Xu… - The Journal of …, 2024 - Am Soc Clin Investig
Several canonical translocations produce oncofusion genes that can initiate acute myeloid
leukemia (AML). Although each translocation is associated with unique features, the …

How we use molecular minimal residual disease (MRD) testing in acute myeloid leukaemia (AML)

R Dillon, N Potter, S Freeman… - British Journal of …, 2021 - Wiley Online Library
In recent years there have been major advances in the use of molecular diagnostic and
monitoring techniques for patients with acute myeloid leukaemia (AML). Coupled with the …

Cohesin mutations in myeloid malignancies

JC Jann, Z Tothova - Blood, The Journal of the American …, 2021 - ashpublications.org
Cohesin is a multisubunit protein complex that forms a ring-like structure around DNA. It is
essential for sister chromatid cohesion, chromatin organization, transcriptional regulation …

A genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways that mediate resistance to sorafenib in acute myeloid leukemia

A Damnernsawad, D Bottomly, SE Kurtz… - …, 2020 - pmc.ncbi.nlm.nih.gov
Drug resistance impedes the long-term effect of targeted therapies in acute myeloid
leukemia (AML), necessitating the identification of mechanisms underlying resistance …

Unique role of DDX41, a DEAD-box type RNA helicase, in hematopoiesis and leukemogenesis

S Shinriki, H Matsui - Frontiers in oncology, 2022 - frontiersin.org
In myeloid malignancies including acute myeloid leukemia (AML) and myelodysplastic
syndromes (MDS), patient selection and therapeutic strategies are increasingly based on …

HERC ubiquitin ligases in cancer

J Sala-Gaston, A Martinez-Martinez, L Pedrazza… - Cancers, 2020 - mdpi.com
HERC proteins are ubiquitin E3 ligases of the HECT family. The HERC subfamily is
composed of six members classified by size into large (HERC1 and HERC2) and small …